Amphotericin B Completed Phase 3 Trials for Disseminated Leishmaniasis Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02025491Liposomal Amphotericin in Disseminated Leishmaniasis